Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Drug delivery

September 30, 2025 Drug delivery / Pharma applications

Metal-Organic Frameworks Nanoparticles in the Diagnosis and Treatment of Breast Cancer

Breast cancer remains the most prevalent malignancy among women and the second leading cause of cancer-related mortality worldwide, primarily attributable

Continue reading

September 29, 2025 Drug delivery / Pharma applications

Fe3O4@β-cyclodextrin Nanosystem for melanoma treatment

The high occurrence of melanoma and its associated poor prognosis highlight the need for exploring new and innovative treatment strategies.

Continue reading

September 23, 2025 Drug delivery / Pharma applications

Cyclodextrin-based nanosponge co-delivery of doxorubicin and EMD: synergistic anticancer activity with improved selectivity toward cancer cells

Combination therapy has emerged as a promising strategy in cancer treatment, aiming to enhance therapeutic efficacy and overcome drug resistance.

Continue reading

September 19, 2025 Drug delivery / Pharma applications

Special Issue: Bioactive Phytochemicals from Medicinal Plants: Formulation and Therapeutic Potential

The special issue is organized by Pharmaceutics, an open access journal. Guest Editors: Dr. Ademar Alves Da Silva Filho, Dr.

Continue reading

September 18, 2025 Drug delivery / Pharma applications

Short Resumé of MagnetoCyclodextrins: Synthesis, challenges, and opportunities

The review “MagnetoCyclodextrins: Synthesis, challenges, and opportunities” explores MagnetoCyclodextrins (MNP CDs), hybrid nanomaterials created by combining the magnetic properties of

Continue reading

September 17, 2025 Drug delivery / Pharma applications

Cyclodextrin-AmB-IL-10 antagonist peptide nanoparticles treat leishmaniasis more effectively than conventional Amphotericin B

This study aimed to create a new nanotherapeutic strategy by combining an interleukin-10 (IL-10) peptide antagonist with amphotericin B (AmB)

Continue reading

September 16, 2025 CD as API / Drug delivery / Pharma applications

Cyclodextrin-based therapeutics delivery systems: A review of current clinical trials

Cyclodextrins (CDs) and their polymers are gaining momentum as advanced drug delivery systems. A recent review (https://www.sciencedirect.com/science/article/pii/S2590257125000203) highlights their progress

Continue reading

September 11, 2025 Drug delivery / Pharma applications

Multiple therapeutic benefits of Sulforaphane/alpha-cyclodextrin complex

Introduction: Sulforaphane (SFN) is a naturally occurring isothiocyanate (Fig.1) associated with various health benefits, including reduced cancer risk, and has

Continue reading

September 10, 2025 Drug delivery / Pharma applications

Cyclodextrin-Based Delivery Systems for Flavonoids: Mechanisms, Advances, Formulation, and Application Opportunities

In this review the structural characteristics and complexation mechanisms of various flavonoid-cyclodextrin complexes were summarized and their influence on biological

Continue reading

September 4, 2025 Drug delivery / Pharma applications

Enhanced Solubility and Rapid Delivery of Vitamin D3 via Sulfobutyl Ether β-Cyclodextrin Inclusion Complex in Mouth-Dissolving Films

This study successfully demonstrates the preparation of a vitamin D3:SBE-BCD inclusion complex using an eco-friendly, microwave-assisted method that minimizes solvent

Continue reading

Posts pagination

«Previous Posts 1 … 9 10 11 12 13 … 82 Next Posts»

Recent Posts

  • Cyclodextrins may help a therapeutic agent en route to the brain
  • Enhancing Foamability of Oat Milk with In Situ Generated Cyclodextrins
  • 1-Methylcyclopropene: from the CD cavity to the apple tree
  • β-Cyclodextrin inclusion complexes as supramolecular carriers: Established and emerging applications in the food industry
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (74)
  • CD as API (357)
  • CD derivatives (435)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (819)
  • E-ducation (63)
  • Environmental (144)
  • Events (241)
  • Food (236)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (419)
  • Other industrial use (113)
  • Pharma applications (1,223)
  • Supramolecular systems (44)
  • Uncategorized (169)

Top Posts

  • Cyclodextrins may help a therapeutic agent en route to the brain
  • Enhancing Foamability of Oat Milk with In Situ Generated Cyclodextrins
  • Lanosterol eye drops for cataract treatment
  • β-Cyclodextrin inclusion complexes as supramolecular carriers: Established and emerging applications in the food industry
  • Positively Charged Fluorine-Free Cyclodextrin Nanosponges for PFAS Removal
  • How air fresheners work?
  • Three Birds, One Excipient: Development of an Improved pH, Isotonic, and Buffered Ketamine Formulation for Subcutaneous Injection
  • Antiepileptic drug with betadex sulfobutyl ether sodium, Fycompa® injection approved in Japan
  • Adsorption of PFAS to Cationic β-Cyclodextrin Polymers
  • First cannabidiol product approved by FDA as medication

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,458 other subscribers
Loading Comments...